)
Ginette Serrero, PhD
Chief Executive Officer,
Biosketch
Dr. Ginette Serrero is CEO of Precision Antibody, an international leader in the custom development of monoclonal antibodies for the treatment and diagnosis of human diseases. She draws on biotech management and research expertise in Oncology to guide the company's strategy, vision and accomplishments. Her laboratory discovered Progranulin as a marker of cancer recurrence, drug resistance and tumor aggressiveness, developing two companion diagnostics and a first-in-class, first-in-human antibody therapeutic in phase 1 clinical trial. She is a Biochemist expert in target discovery and biomarker identification.
She holds several patents on Oncology targets and authored more than 100 peer-reviewed scientific publications.
Sessions